These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38860604)

  • 1. The mechanism of RGS5 regulating gastric cancer mismatch repair protein.
    Yang Z; Zhang R; Liu J; Tian S; Zhang H; Zeng L; Zhang Y; Gao L; Wang M; Shan W; Liu J
    Mol Carcinog; 2024 Sep; 63(9):1750-1767. PubMed ID: 38860604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status.
    Wang L; Zhang Q; Ni S; Tan C; Cai X; Huang D; Sheng W
    Cancer Med; 2018 Jun; 7(6):2612-2620. PubMed ID: 29673110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma.
    Melaiu O; Mina M; Chierici M; Boldrini R; Jurman G; Romania P; D'Alicandro V; Benedetti MC; Castellano A; Liu T; Furlanello C; Locatelli F; Fruci D
    Clin Cancer Res; 2017 Aug; 23(15):4462-4472. PubMed ID: 28270499
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel protein FNDC3B-267aa encoded by circ0003692 inhibits gastric cancer metastasis via promoting proteasomal degradation of c-Myc.
    Liu YY; Zhang YY; Ran LY; Huang B; Ren JW; Ma Q; Pan XJ; Yang FF; Liang C; Wang XL; Wang SM; Ran A; Ning H; Jiang Y; Qin CH; Xiao B
    J Transl Med; 2024 May; 22(1):507. PubMed ID: 38802851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer.
    Zhou C; Che G; Zheng X; Qiu J; Xie Z; Cong Y; Pei X; Zhang H; Sun H; Ma H
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2663-2674. PubMed ID: 31541338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
    Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATE1 Inhibits Liver Cancer Progression through RGS5-Mediated Suppression of Wnt/β-Catenin Signaling.
    Xu C; Li YM; Sun B; Zhong FJ; Yang LY
    Mol Cancer Res; 2021 Sep; 19(9):1441-1453. PubMed ID: 34158395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
    Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y
    BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer.
    Wang C; Chen Y; Zhou R; Yang Y; Fang Y
    Curr Med Chem; 2024; 31(17):2467-2482. PubMed ID: 37936456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
    Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
    Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
    Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
    EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.
    Shi J; Yang X; Wang X; Luo Y; Zhou W; Luo H; Bianba Z; Nima Z; Wang Q; Wang H; Liao R; Ciren Q; Li M; Pang J
    Biomed Res Int; 2022; 2022():2684065. PubMed ID: 35734348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-449c-5p availability is antagonized by circ-NOTCH1 for MYC-induced NOTCH1 upregulation as well as tumor metastasis and stemness in gastric cancer.
    Zhao X; Zhong Q; Cheng X; Wang S; Wu R; Leng X; Shao L
    J Cell Biochem; 2020 Oct; 121(10):4052-4063. PubMed ID: 31943342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis.
    Sun L; Wang Q; Chen B; Zhao Y; Shen B; Wang H; Xu J; Zhu M; Zhao X; Xu C; Chen Z; Wang M; Xu W; Zhu W
    Cell Death Dis; 2018 Sep; 9(9):928. PubMed ID: 30206229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
    Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
    Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study.
    Beer A; Taghizadeh H; Schiefer AI; Puhr HC; Karner AK; Jomrich G; Schoppmann SF; Kain R; Preusser M; Ilhan-Mutlu A
    Pathol Oncol Res; 2020 Oct; 26(4):2225-2235. PubMed ID: 32372174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
    Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of C-MYC in gastric adenocarcinoma is associated with PD-L1 and FOXP3 expression: C-MYC overexpression is a good prognostic factor.
    Won KY; Kim GY; Kim HK; Song MJ; Choi SI; Bae GE; Lim SJ
    Pathol Res Pract; 2019 Nov; 215(11):152639. PubMed ID: 31582185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancer.
    Xu L; Liu J; An Y; Zhou L; Sun H; Xu Z; Wang D; Liang Z; Xu C; Wang B; Li W
    BMC Cancer; 2024 Aug; 24(1):979. PubMed ID: 39118022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS5 decreases the proliferation of human ovarian carcinoma‑derived primary endothelial cells through the MAPK/ERK signaling pathway in hypoxia.
    Wang D; Xu Y; Feng L; Yin P; Song SS; Wu F; Yan P; Liang Z
    Oncol Rep; 2019 Jan; 41(1):165-177. PubMed ID: 30365142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.